• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anteris Technologies Global Corp. - Common Stock (NQ:AVR)

4.550 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Anteris Technologies Global Corp. - Common Stock

News headline image
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
November 17, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Announces Results for the Third Quarter of 2025
November 12, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
November 03, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris DurAVR® THV Demonstrates Favorable Hemodynamics in Small Annuli Patients with no Valve Related Mortality at One Year
October 28, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
October 27, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Technologies Announces One-Year Clinical Outcomes for DurAVR® THV to be Presented at TCT® 2025
October 27, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Receives First European Regulatory Clearance to Commence DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
October 15, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Technologies Global Corp. Announces Adjournment of Special Meeting of Stockholders
September 19, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
September 11, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders
September 04, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Announces Results for the Second Quarter of 2025
August 11, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors
June 09, 2025
New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities 
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Announces Results for the First Quarter of 2025
May 13, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV
March 31, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Reports One-Year Patient Outcomes for DurAVR® THV
March 21, 2025
New class, biomimetic TAVR demonstrates sustained hemodynamic performance to one-year 
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Reports 2024 Financial Results and Provides Corporate Update
March 12, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays
February 28, 2025
From Anteris Technologies Global Corp.
Via GlobeNewswire
News headline image
Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering
December 16, 2024
From Anteris Technologies Global Corp.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap